It is indicated as an adjunct to diet and exercise for the management of blood glucose in adults with Type 2 Diabetes Mellitus (T2DM)
doi: 10.3389/fpsyt.2024.1491417 Received 04 September 2024 Accepted 29 October 2024 Published 12 November 2024 Volume 15 - 2024 Edited by Mirko Manchia, University of Cagliari, Italy Reviewed by Francesco Monaco, Azienda Sanitaria Locale Salerno, Italy Kristen Ward, University of Michigan, United States Updates Copyright 2024 Fitzgerald, Sahm, N Dhubhlaing, ODwyer, OConnell, Torrens and Crowley
Possible Side Effects Side effects are uncommon but may include mild soreness at the injection site or a temporary headache
Their ability to slow gastric emptying and reduce postprandial glucose excursions further contributes to metabolic stability
There is no published pharmacokinetic data in humans, meaning we do not know how the peptide is absorbed, distributed, metabolized, or excreted